• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Ordaos

Thursday, June 06, 2024
Platform for Therapeutics
Company Presentation Theater 1
Ordaos is creating the next generation of biologics 30x faster than has ever been possible with its lab-in-the-loop generative AI mini-protein design engine. Ordaos designs mini proteins using the Ordaos Design Engine to reduce side effects and increase drug effectiveness. As a generative AI platform, the engine simultaneously maximizes binding, stability, and manufacturability while minimizing immunogenicity and development risks as it creates proteins one amino acid at a time to meet patients’ specific needs. Ordaos' lab-in-the-loop validates its digital hypotheses and generates valuable data to train its AI models. Using its Design Engine, Ordaos is setting its sights on world-changing issues including blood-brain-barrier penetration, orally-delivered biologics, and pandemic preparedness. With both an internal program and external partnerships with biotech and large pharma alike, Ordaos is rethinking biologics discovery as biologics design.
Ordaos
Company Website: https://www.ordaos.bio
Lead Product in Development: Trop2 BiTE VHH, CD33 VHH

Company HQ City

New York

Company HQ State

New York

Company HQ Country

United States

CEO/Top Company Official

David Longo

Development Phase of Primary Product

Pre-Clinical
Primary Speaker
David Longo, MS
CEO
Ordaos
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS